Atg32 is an outer mitochondrial membrane protein in Saccharomyces cerevisiae that functions as the primary receptor for mitophagy. It confers selectivity for mitochondrial sequestration as cargo and is necessary for recruitment of mitochondria by the autophagy machinery . The protein acts as a molecular tag that identifies mitochondria for degradation under specific conditions such as nutrient starvation or during quality control of damaged mitochondria . Cells lacking Atg32 (atg32Δ mutants) are specifically deficient in mitophagy while maintaining normal function in other selective autophagy pathways and non-specific macroautophagy .
Atg32 contains multiple functional domains that are critical for its role in mitophagy:
An N-terminal domain that extends into the cytosol
A transmembrane domain that anchors the protein to the outer mitochondrial membrane
A C-terminal domain that extends into the intermembrane space
A pseudo-receiver (PsR) domain (residues 1-199) that is essential for mitophagy initiation
The solution structure of the PsR domain was determined by NMR spectroscopy, revealing a previously undescribed structural element that regulates Atg32 activation . Additionally, the region between amino acids 200-341 appears dispensable for mitophagy function, as Atg32Δ200-341 still localizes to mitochondria and is expressed at comparable levels to full-length Atg32 .
Atg32 serves as a crucial adaptor that connects mitochondria to the core autophagy machinery through two primary interactions:
Atg32-Atg11 interaction: Upon mitophagy induction, Atg32 is phosphorylated at Ser114 and Ser119 by casein kinase 2 (CK2), which enables binding to Atg11 . This interaction recruits mitochondria to the phagophore assembly site (PAS) .
Atg32-Atg8 interaction: Atg32 also interacts with Atg8, which is anchored on the isolation membrane. This interaction facilitates the formation of the autophagosome surrounding the mitochondria .
These protein-protein interactions have been verified through yeast two-hybrid assays and co-immunoprecipitation experiments, confirming their physiological relevance .
Atg32 expression is subject to complex transcriptional regulation:
| Regulatory Element | Function in Atg32 Transcription |
|---|---|
| Ume6-Sin3-Rpd3 complex | Suppresses ATG32 transcription by binding to the upstream repression sequence (URS) of the ATG32 promoter region |
| TOR (Target of Rapamycin) | Inhibition of TOR releases the Ume6-Sin3-Rpd3 complex, allowing ATG32 transcription |
| Growth phase | ATG32 promoter activity increases through the course of cell growth, with 3-4 fold higher expression in stationary phase compared to early exponential phase |
Analysis of ATG32 promoter activity using a pPROM-ATG32-β-galactosidase reporter construct has shown that ATG32 transcription increases as cells progress from exponential to stationary phase . Interestingly, while transcription increases, the actual protein levels decrease, suggesting post-transcriptional regulation plays a significant role in controlling Atg32 abundance .
Atg32 activity is regulated by multiple post-translational modifications:
Phosphorylation:
Ubiquitination:
Atg32 is ubiquitinated at Lysine 282, as confirmed by LC-MS/MS analysis
This ubiquitination targets Atg32 for proteasomal degradation
Inhibition of proteasome activity with MG-132 prevents Atg32 degradation, stabilizing the protein during stationary phase, nitrogen starvation, and rapamycin treatment
These modifications create a sophisticated regulatory network that finely tunes Atg32 levels and activity in response to cellular conditions.
The pseudo-receiver (PsR) domain (residues 1-199) of Atg32 plays a critical role in mitophagy:
It is essential for the proteolysis of the C-terminal domain of Atg32 and subsequent recruitment of Atg11
The solution structure determined by NMR spectroscopy revealed a previously undescribed structural element
Deletion experiments have shown that the PsR domain is required for nitrogen starvation-induced mitophagy
Researchers have determined that even when the large portion of the cytosolic domain (residues 200-341) is removed, Atg32 still localizes to mitochondria and is expressed at levels comparable to the full-length protein . This suggests that the PsR domain contains the key functional elements required for mitophagy induction.
Several experimental approaches can be employed to study mitophagy in yeast:
Om45-GFP processing assay:
GFP-Atg8 processing assay:
Microscopy-based assays:
Fluorescence microscopy to track mitochondrial markers and their colocalization with vacuolar markers
Can be used to visualize the recruitment of Atg32 to specific mitochondrial sites during mitophagy induction
Biochemical fractionation:
Isolation of mitochondria and measurement of mitochondrial protein degradation
Particularly useful for quantitative assessment of mitophagy rates
Creating and validating Atg32 mutants involves several crucial steps:
Design of mutations:
Target specific domains (e.g., PsR domain)
Target sites of post-translational modifications (e.g., phosphorylation sites Ser114/Ser119, ubiquitination site Lys282)
Create truncation mutants to study domain functions (e.g., Atg32Δ200-341)
Expression verification:
Functional validation:
For example, researchers have validated that Atg32Δ200-341 still localizes to mitochondria despite the loss of a large portion of the cytosolic domain, demonstrating that this region is not essential for targeting to the mitochondrial outer membrane .
Several approaches can be used to study Atg32 ubiquitination:
Proteasome inhibition assays:
Protein purification and mass spectrometry:
Mutational analysis:
Mutation of ubiquitination sites (e.g., K282R) to assess functional consequences
Comparison of wild-type and mutant Atg32 stability and mitophagy efficiency
Using these techniques, researchers have identified Lysine 282 as a specific ubiquitination site in Atg32, as evidenced by the detection of the characteristic diglycine (GG) tag remaining after tryptic proteolysis of ubiquitinated proteins .
Distinguishing between different roles of Atg32 requires careful experimental design:
Use of specific autophagy mutants:
Domain-specific mutations:
Create mutants affecting specific functions (e.g., phosphorylation sites vs. ubiquitination sites)
Assess different cellular responses and mitochondrial phenotypes
Temporal analysis:
Monitor Atg32 levels and modifications at different time points
Correlate with mitochondrial function, morphology, and degradation rates
Researchers have observed that Atg32 levels decrease in the stationary phase even in autophagy-defective mutants (atg5Δ, atg8Δ, atg11Δ), suggesting that Atg32 might be involved in yet unknown pathways related to mitochondrial functions beyond its role in mitophagy .
Several technical challenges must be addressed when studying Atg32:
Protein modification complexity:
Atg32 undergoes multiple modifications (phosphorylation, ubiquitination)
These modifications may be interdependent and occur under specific conditions
Protein aggregation issues:
Conditional expression:
Atg32 levels change dramatically under different growth conditions
Careful timing of experiments is critical for reproducible results
Dual degradation pathways:
Atg32 regulation varies under different stress conditions:
Understanding these condition-specific regulatory mechanisms is crucial for designing experiments that accurately capture the physiological roles of Atg32 in mitochondrial quality control and cellular adaptation to stress.
The interplay between different post-translational modifications of Atg32 represents an important frontier in research:
Sequential modification hypothesis:
Phosphorylation at Ser114/Ser119 may precede or influence ubiquitination at Lys282
These modifications may work together to regulate Atg32 activity and stability
Experimental approaches:
Creation of phospho-mimetic and phospho-deficient mutants to study effects on ubiquitination
Analysis of ubiquitination patterns in CK2 mutants with reduced phosphorylation capability
Time-course experiments to determine the sequence of modifications
Functional significance:
Further investigation of how these modifications interact could reveal sophisticated regulatory mechanisms that fine-tune mitophagy in response to different cellular conditions.
Development of tools for temporal control of Atg32 activity would advance the field:
Inducible expression systems:
Galactose-inducible promoters for controlled expression
Tetracycline-responsive systems for finer temporal control
Optogenetic approaches:
Light-inducible dimerization systems to control Atg32-Atg11 interactions
Photocleavable inhibitory domains to rapidly activate Atg32
Chemical genetics:
Engineering Atg32 to respond to small molecule inducers
Development of rapid degradation systems (e.g., auxin-inducible degrons) to control Atg32 levels
Monitoring tools:
Development of FRET-based sensors to monitor Atg32 conformational changes or interactions
Split fluorescent protein systems to visualize Atg32-Atg11 interactions in real-time
These approaches would enable researchers to dissect the kinetics and threshold effects in mitophagy initiation and progression.
Comprehensive mapping of the Atg32 interactome requires multiple complementary approaches:
Proximity labeling methods:
BioID or APEX2 fusions to Atg32 to label proximal proteins
Time-course experiments to capture dynamic interaction changes
Quantitative proteomics:
SILAC or TMT labeling to compare interactors under different conditions
Cross-linking mass spectrometry to capture transient interactions
Genetic screens:
Synthetic genetic array analysis to identify functional interactions
CRISPR screens to identify genes affecting Atg32-mediated mitophagy
Structural biology approaches:
Cryo-EM studies of Atg32-containing complexes
Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
These approaches would help identify additional components of the mitophagy machinery and potentially reveal new functions of Atg32 beyond its established role in mitophagy.